| Year | Client | Period | Income | Expenses | Doc |
|---|---|---|---|---|---|
| 2026 | ALNYLAM PHARMACEUTICALS, INC. |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
— | $430,000 | |
| 2025 | ALNYLAM PHARMACEUTICALS, INC. |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
— | $390,000 | |
| 2025 | ALNYLAM PHARMACEUTICALS, INC. |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
— | $390,000 | |
| 2025 | ALNYLAM PHARMACEUTICALS, INC. |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
— | $390,000 | |
| 2025 | ALNYLAM PHARMACEUTICALS, INC. |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
— | $440,000 | |
| 2024 | ALNYLAM PHARMACEUTICALS, INC. |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
— | $500,000 | |
| 2024 | ALNYLAM PHARMACEUTICALS, INC. |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
— | $480,000 | |
| 2024 | ALNYLAM PHARMACEUTICALS, INC. |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
— | $480,000 | |
| 2024 | ALNYLAM PHARMACEUTICALS, INC. |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
— | $290,000 | |
| 2023 | ALNYLAM PHARMACEUTICALS, INC. |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
— | $220,000 |
| Client | Filings | Total Income |
|---|---|---|
| ALNYLAM PHARMACEUTICALS, INC. | 12 | — |
| Name | Disclosed Prior Position |
|---|---|
| DEIRDRE BRADFORD PARSONS | |
| CURTIS RHYNE | Rep. Virginia Foxx (2008-2009), House Republican Study Committee (2009-2014), Rep. Richard Hudson (2014-2017), Rep. Geo… |
| CHASE THOMAS |